Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 3.58 % |
3 Month Return | -12.04 % |
1 Year Return | -33.65 % |
Market Stats | |
Previous Close | ₹6.94 |
Open | ₹7.08 |
Volume | 10.42K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹52.58Cr |
P/E Ratio | -173.5 |
PEG Ratio | -468.92 |
Market Cap | ₹52.58 Cr |
P/B Ratio | -8.95 |
EPS | -0.09 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹52.58 Cr | 40.09% | 1.11 | -₹1 Cr | NA | |
NA | ₹2,619.80 Cr | 361.65% | 0.82 | NA | NA | |
HOLD | ₹24,440.70 Cr | 19.25% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
NA | ₹220.90 Cr | 22.21% | 0.56 | ₹3 Cr | ₹47 Cr | |
NA | ₹113.41 Cr | 5.32% | 0.50 | ₹45 Cr | ₹59 Cr |
Organisation | Transgene Biotek Ltd |
Headquarters | |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Transgene Biotek Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Unchanged
Promoters holdings remained unchanged at 21.68% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Vimta Labs Ltd has given 151.2% return, outperforming this stock by 95.2%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 70.04% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Vimta Labs Ltd has given 145.7% return, outperforming this stock by 179.4%
Revenue Fall
Revenue is down for the last 2 quarters, 0.7 Cr → 0.1 Cr (in ₹), with an average decrease of 85.7% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 0.2 Cr → -0.07 Cr (in ₹), with an average decrease of 135.0% per quarter
Price Dip
In the last 1 year, Transgene Biotek stock has moved down by -33.7%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 21.68% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 70.04% | 0.00 | |
Others | 8.28% | 0.00 |
Transgene Biotek Ltd in the last 5 years
Lowest (-207.00x)
July 12, 2024
Today (-173.50x)
December 24, 2024
Industry (101.75x)
December 24, 2024
Highest (13.23x)
October 8, 2018
Bearish
Neutral
Bullish
Transgene Biotek Ltd is currently in a Bullish trading position according to technical analysis indicators.
Transgene Biotek Ltd (526139) share price today is ₹7.31
Transgene Biotek Ltd is not listed on NSE
Transgene Biotek Ltd is listed on BSE
PE Ratio of Transgene Biotek Ltd is -173.5
PE ratio = Transgene Biotek Ltd Market price per share / Transgene Biotek Ltd Earnings per share
Today’s traded volume of Transgene Biotek Ltd(526139) is 10.42K.
Today’s market capitalisation of Transgene Biotek Ltd(526139) is ₹52.58Cr.
Transgene Biotek Ltd(526139 | Price |
---|---|
52 Week High | ₹12.46 |
52 Week Low | ₹5.79 |
Transgene Biotek Ltd(526139) share price is ₹7.31. It is down -41.33% from its 52 Week High price of ₹12.46
Transgene Biotek Ltd(526139) share price is ₹7.31. It is up 26.25% from its 52 Week Low price of ₹5.79
Transgene Biotek Ltd(526139 | Returns |
---|---|
1 Day Returns | 0.37% |
1 Month Returns | 3.58% |
3 Month Returns | -12.04% |
1 Year Returns | -33.65% |